An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine 750-2000 mg/d in the Treatment of Manic Episodes of Bipolar I Disorder
Clinical trial NCT00238485 · COMPLETED
Trial details
- NCT number
- NCT00238485
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2007-07-01
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.